In The News
ACCC raises concerns about Qube’s plan to buy Melbourne terminal operator
Bayer’s patents for blockbuster blood thinner Xarelto invalid: court
Coles, Woolworths say ACCC’s dodgy discounts case ‘just misconceived’
INPEX can cross-examine AkzoNobel’s lawyers over ‘inadequate’ discovery
QBE made empty promises on policy discounts, ASIC says in new case
Bruce Lehrmann clears hurdle to appeal defamation loss
Enviro group loses appeal over planned burns in greater glider habitat
Couple wins suit over ‘misleading’ $9.6M South Yarra apartment sale
Lawyer found to have yelled at opposing solicitor can’t appeal sacking
Football player sues amateur league over on-field cardiac arrest
Please login to bookmarkClose

Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au